• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非蛋白呼吸商在肝硬化患者中的预后意义

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.

作者信息

Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Ishii Akio, Nishimura Takashi, Yoh Kazunori, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei

机构信息

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

出版信息

Medicine (Baltimore). 2017 Jan;96(3):e5800. doi: 10.1097/MD.0000000000005800.

DOI:10.1097/MD.0000000000005800
PMID:28099336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5279081/
Abstract

The aim of this study was to examine the effect of nonprotein respiratory quotient (npRQ), as assessed using indirect calorimetry, on clinical outcomes in patients with liver cirrhosis (LC). A total of 244 LC patients were evaluated in this study. For the univariate analysis, for each continuous variable, the optimal cutoff value that maximized the sum of sensitivity and specificity was selected using receiver operating curve (ROC) analysis for survival. There were 137 men and 107 women with the median (range) age of 67 (25-90) years. Indirect calorimetry indicated that 54 patients (22.1%) had hepatocellular carcinoma (HCC) on radiological findings and 59 patients (24.2%) had protein energy malnutrition, as defined by npRQ <0.85 and serum albumin level <3.5 g/dL. In ROC analysis of npRQ for survival, the optimal cutoff point of npRQ was 0.849 for all cases (area under the ROC = 0.61272; sensitivity, 66.22%; and specificity, 57.06%). The median follow-up periods after indirect calorimetry were 4.35 years (range, 1.01-9.66 years) in patients with npRQ ≥0.85 (n = 122) and 3.71 years (range, 0.19-9.51 years) in patients with npRQ <0.85 (n = 122). The 1-, 3-, and 5-year cumulative OS rates in patients with npRQ ≥0.85 were 100%, 87.79%, and 77.24%, respectively, whereas those in patients with npRQ <0.85 were 94.26%, 73.65% and 57.78%, respectively (P = 0.0004). In the multivariate analysis, presence of HCC (P = 0.0045), body mass index (P < 0.0001), serum albumin (P = 0.0441), prothrombin time (P = 0.0463), npRQ (P = 0.0024), estimated glomerular filtration rate (P = 0.0086), and des-γ-carboxy prothrombin (P = 0.0268) were found to be significant predictors associated with OS. For all cases, risk stratification for survival was well performed using these significant variables. In conclusion, npRQ value, as assessed by indirect calorimetry, can be helpful for predicting clinical outcomes for LC patients.

摘要

本研究的目的是探讨使用间接测热法评估的非蛋白呼吸商(npRQ)对肝硬化(LC)患者临床结局的影响。本研究共评估了244例LC患者。在单因素分析中,对于每个连续变量,使用生存的受试者工作特征曲线(ROC)分析选择使敏感性和特异性之和最大化的最佳截断值。共有137名男性和107名女性,年龄中位数(范围)为67(25 - 90)岁。间接测热法显示,54例患者(22.1%)经影像学检查发现患有肝细胞癌(HCC),59例患者(24.2%)存在蛋白质能量营养不良,定义为npRQ < 0.85且血清白蛋白水平 < 3.5 g/dL。在npRQ对生存的ROC分析中,所有病例的npRQ最佳截断点为0.849(ROC曲线下面积 = 0.61272;敏感性为66.22%;特异性为57.06%)。npRQ≥0.85的患者(n = 122)间接测热法后的中位随访期为4.35年(范围1.01 - 9.66年),npRQ < 0.85的患者(n = 122)为3.71年(范围0.19 - 9.51年)。npRQ≥0.85的患者1年、3年和5年累积总生存率分别为100%、87.79%和77.24%,而npRQ < 0.85的患者分别为94.26%、73.65%和57.78%(P = 0.0004)。在多因素分析中,发现HCC的存在(P = 0.0045)、体重指数(P < 0.0001)、血清白蛋白(P = 0.0441)、凝血酶原时间(P = 时0.0463)、npRQ(P = 0.0024)、估计肾小球滤过率(P = 0.0086)和去γ - 羧基凝血酶原(P = 0.0268)是与总生存相关的显著预测因素。对于所有病例,使用这些显著变量对生存进行风险分层效果良好。总之,通过间接测热法评估的npRQ值有助于预测LC患者的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/56daf19a5783/medi-96-e5800-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/39d2c2d4ba27/medi-96-e5800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/7ab7c02d8f34/medi-96-e5800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/ced462f4fd16/medi-96-e5800-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/56daf19a5783/medi-96-e5800-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/39d2c2d4ba27/medi-96-e5800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/7ab7c02d8f34/medi-96-e5800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/ced462f4fd16/medi-96-e5800-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c87/5279081/56daf19a5783/medi-96-e5800-g010.jpg

相似文献

1
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.非蛋白呼吸商在肝硬化患者中的预后意义
Medicine (Baltimore). 2017 Jan;96(3):e5800. doi: 10.1097/MD.0000000000005800.
2
Indirect calorimetry and anthropometry to estimate energy metabolism in patients with liver cirrhosis.间接测热法和人体测量法用于评估肝硬化患者的能量代谢。
J Nutr Sci Vitaminol (Tokyo). 2010;56(6):372-9. doi: 10.3177/jnsv.56.372.
3
Albumin-bilirubin score as a useful predictor of energy malnutrition in patients with hepatocellular carcinoma.白蛋白-胆红素评分可作为肝癌患者能量营养不良的有用预测指标。
Clin Nutr. 2021 May;40(5):3585-3591. doi: 10.1016/j.clnu.2020.12.023. Epub 2020 Dec 21.
4
Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.慢性肝病患者的血清锌水平与非蛋白呼吸商
J Clin Med. 2020 Jan 17;9(1):255. doi: 10.3390/jcm9010255.
5
Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.慢性肝病患者白蛋白-胆红素分级与非蛋白呼吸商之间的关联
J Clin Med. 2019 Sep 18;8(9):1485. doi: 10.3390/jcm8091485.
6
Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.短期非蛋白呼吸商和前白蛋白的降低可能与肝细胞癌患者经导管动脉化疗栓塞后肝功能的长期恶化有关。
J Gastroenterol. 2012 Jun;47(6):704-14. doi: 10.1007/s00535-012-0535-x. Epub 2012 Feb 18.
7
Prognostic value of energy metabolism in patients with viral liver cirrhosis.
Nutrition. 2002 Mar;18(3):229-34. doi: 10.1016/s0899-9007(01)00754-7.
8
Free fatty acid as a marker of energy malnutrition in liver cirrhosis.游离脂肪酸作为肝硬化能量营养不良的标志物。
Hepatol Res. 2014 Feb;44(2):218-28. doi: 10.1111/hepr.12112. Epub 2013 Apr 18.
9
[Energy metabolism characteristic with risk of secondary bacterial infection in patients with hepatitis B virus-related chronic liver disease].[乙型肝炎病毒相关慢性肝病患者继发细菌感染风险的能量代谢特征]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):558-564. doi: 10.3760/cma.j.cn501113-20210130-00052.
10
Clinical use of the respiratory quotient obtained from indirect calorimetry.间接测热法所得呼吸商的临床应用。
JPEN J Parenter Enteral Nutr. 2003 Jan-Feb;27(1):21-6. doi: 10.1177/014860710302700121.

引用本文的文献

1
Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.导致肝硬化患者营养不良和肌肉减少症的分子机制。
Int J Mol Sci. 2020 Jul 28;21(15):5357. doi: 10.3390/ijms21155357.
2
Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.慢性肝病患者的血清锌水平与非蛋白呼吸商
J Clin Med. 2020 Jan 17;9(1):255. doi: 10.3390/jcm9010255.
3
Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.

本文引用的文献

1
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.无干扰素治疗的持续病毒学应答可改善 HCV 引起的门静脉高压。
J Hepatol. 2016 Oct;65(4):692-699. doi: 10.1016/j.jhep.2016.05.027. Epub 2016 May 27.
2
Recent Advances in Antiviral Therapy for Chronic Hepatitis C.慢性丙型肝炎抗病毒治疗的最新进展
Mediators Inflamm. 2016;2016:6841628. doi: 10.1155/2016/6841628. Epub 2016 Jan 31.
3
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
慢性肝病患者白蛋白-胆红素分级与非蛋白呼吸商之间的关联
J Clin Med. 2019 Sep 18;8(9):1485. doi: 10.3390/jcm8091485.
4
Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis.乙型肝炎相关肝硬化患者发生的肝细胞癌中的肝功能和能量代谢
Medicine (Baltimore). 2019 May;98(19):e15528. doi: 10.1097/MD.0000000000015528.
5
Effects of Late Evening Snack on Cirrhotic Patients: A Systematic Review and Meta-Analysis.晚间小吃对肝硬化患者的影响:一项系统评价和荟萃分析。
Gastroenterol Res Pract. 2018 Apr 1;2018:9189062. doi: 10.1155/2018/9189062. eCollection 2018.
日本肝脏学会丙型肝炎病毒感染管理指南:2016年1型和2型更新版
Hepatol Res. 2016 Feb;46(2):129-65. doi: 10.1111/hepr.12645.
4
Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.综述文章:肝硬化中的肌肉减少症——病因、影响及潜在治疗干预措施
Aliment Pharmacol Ther. 2016 Apr;43(7):765-77. doi: 10.1111/apt.13549. Epub 2016 Feb 5.
5
Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry.慢性肝病中与蛋白质 - 能量营养不良相关的因素:使用间接测热法的分析
Medicine (Baltimore). 2016 Jan;95(2):e2442. doi: 10.1097/MD.0000000000002442.
6
Current and future directions for treating hepatitis B virus infection.治疗乙型肝炎病毒感染的现状与未来方向。
World J Hepatol. 2015 Jun 18;7(11):1541-52. doi: 10.4254/wjh.v7.i11.1541.
7
Model for End-stage Liver Disease.终末期肝病模型
J Clin Exp Hepatol. 2013 Mar;3(1):50-60. doi: 10.1016/j.jceh.2012.11.002. Epub 2012 Dec 1.
8
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis.左旋肉碱可减少肝硬化患者的肌肉痉挛。
Clin Gastroenterol Hepatol. 2015 Aug;13(8):1540-3. doi: 10.1016/j.cgh.2014.12.005. Epub 2014 Dec 9.
9
Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial.锌对肝硬化伴高氨血症的影响:一项初步随机、安慰剂对照双盲试验
Nutrition. 2014 Nov-Dec;30(11-12):1409-14. doi: 10.1016/j.nut.2014.04.018. Epub 2014 May 10.
10
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.ATP产生来源的转变以及糖酵解能力的丧失是晚期肝病中肝细胞衰竭的标志。
J Hepatol. 2014 Jun;60(6):1203-11. doi: 10.1016/j.jhep.2014.02.014. Epub 2014 Feb 26.